Changes in Beneficial Ownership · 4
Immuneering Corporation
IMRXNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
wk-form4_1781640910.xml
Filing details
- Report period
- 2026-06-15
- Issuer
- Immuneering Corp
- Issuer CIK
- 0001790340
- Trading symbol
- IMRX
Reporting owner 1
- Name
- Hall Brett Matthew
- Reporting owner CIK
- 0001870437
- Relationship
- Officer
- Officer title
- CHIEF SCIENTIFIC OFFICER
- Address
- 245 MAIN STREET, SECOND FLOOR, CAMBRIDGE, MA, 02142
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | 2026-06-15 | P · Form 4 | 6,035 | A | 4.15[F1] | 382,531 | D |
Table key
- P · Form 4
- Purchase on the market or privately
- A
- Acquired
- D
- Direct
Footnotes
- F1
- This transaction was executed in multiple trades through a broker-dealer at prices ranging from $4.146 to $4.15. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price.↩ 1
Signature 1
- Signed
- /s/ Michael D. Bookman, Attorney-in-Fact for Brett Matthew Hall
- Date
- 2026-06-16